Researchers stumbled across the connection while searching for ways to reduce vision problems in people with achromatopsia.

Two studies identify a signaling pathway that contributes to the fish’s sleeplessness.

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

By investigating the science behind “seeing” with sound, researchers hope to help blind individuals independently navigate the world.

Optometrist and eclipse-chaser Ralph Chou describes how even a partially eclipsed sun can damage the eye.

Researchers improve on a technique to use a light-stimulated small molecule to confer longer-term photosensitivity to the retinal cells of blind mice.

An experimental treatment sacrifices rod cell function to save cone cells in mice, preventing retinal degeneration, researchers report. 

A combination of visual stimulation and chemical growth promotion leads damaged retinal nerves to regenerate in mice.

Patient-derived stem cells containing a genetic mutation leading to blindness can be successfully edited using CRISPR/Cas9, researchers show.